Vaxcyte, Inc. PCVX Business Segments — Total other income, net
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Vaxcyte, Inc. in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The official record: Vaxcyte, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Vaxcyte, Inc.'s business segments — total other income, net.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Vaxcyte, Inc.'s business segments — total other income, net?
- Vaxcyte, Inc. (PCVX) reported business segments — total other income, net of $25.23M in Q1 2026.
- How has Vaxcyte, Inc.'s business segments — total other income, net changed year-over-year?
- Vaxcyte, Inc.'s business segments — total other income, net decreased by 37.0% year-over-year, from $40.08M to $25.23M.
- What is the long-term trend for Vaxcyte, Inc.'s business segments — total other income, net?
- Over 3 years (2022 to 2025), Vaxcyte, Inc.'s business segments — total other income, net has grown at a 161.6% compound annual growth rate (CAGR), from $8.77M to $157.05M.
- What does business segments — total other income, net mean?
- This metric represents the net financial results from activities outside of the segment's primary operational focus, such as interest income, investment gains, or other non-core financial items. It reflects the segment's ability to generate supplemental returns on its cash reserves or other assets. A positive value indicates that non-operating activities are contributing to the segment's overall financial position.